Annual branded revenue growth of nearly 16% with broad‑based strength across all markets; Adjusted EBITDA growth outpaced revenue for the year
TORONTO, February 26, 2026–(BUSINESS WIRE)–Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported financial results for its fourth quarter and full year ended December 31, 2025. All amounts are expressed in Canadian dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other financial measures. See “Non-IFRS and Other Financial Measures” below.
Management Commentary
“2025 was an outstanding year for Jamieson Wellness, driven by sustained global demand for our products and superior execution across every key market,” said Mike Pilato, President and CEO. “Our branded business grew nearly 16%, with growth across each of our core geographies. Higher branded sales combined with investments in marketing and innovation expanded gross margins and drove double-digit growth in Adjusted EBITDA and cash flow.
“In China, we grew more than 56% in 2025 as our digital programs and performance marketing continued to deepen consumer engagement, and we’re seeing that translate into material growth in brand health indicators and purchase conversion rates across all major platforms. Youtheory delivered double‑digit growth, with strong consumption across both digital and traditional channels driven by our new e‑commerce strategy and innovation in high-growth categories like stress and energy support.
“In Canada, our quality‑focused marketing campaign and strong innovation continue to resonate with consumers, driving category‑leading performance. Internationally, we delivered solid organic growth across our focus markets as demand remained healthy in key categories such as immunity, sleep, stress and energy.
“As we look to 2026, consumers continue to prioritize their health and wellness, and we’re well-positioned to meet them – across geographies, across channels, and across life stages. We’re focused on accelerating innovation, extending our reach in the markets that matter most, and strengthening our operational foundation as we continue to grow our branded platform on the path to $1 billion in revenue. I’m grateful to the entire Jamieson team for their commitment to our purpose of Inspiring Better Lives Every Day. Together, we are delivering innovative products for our consumers and building long-term value for our shareholders.”
Fiscal 2025 Highlights
Revenue growth in Canada outpaced the market, driven by consumer consumption behind the Company’s quality focused marketing campaign and strong on-trend innovation
Youtheory delivered double-digit revenue growth vs prior year, driven by strong e-commerce consumption, innovation, and new distribution
Revenue in China outpaced the market by 4x, driven by material increases in brand awareness, trial, and consumer conversion to regular buyers
Growth continued in International markets, particularly in core markets in the Middle East, Europe, and the Caribbean, driven by strong local innovation and the Company’s Canadian quality marketing campaign, launched globally
Operating cash flows before working capital considerations grew 23.2% vs prior year, driven by higher earnings, increased operating leverage and strategic pacing of SG&A investments
Successfully implemented new ERP system in Q1 of 2025, modernizing the Company’s data management and digital capabilities to deliver next phase of long-term growth
Summary of Fourth Quarter Consolidated Results
All comparisons are with the fourth quarter of 2024
Consolidated revenue increased 13.4% to $277.7 million, driven by 17.1% growth in Jamieson Brands, partially offset by an expected decline in Strategic Partners revenue
Gross profit increased by $18.5 million to $118.7 million, mainly driven by higher Jamieson Brands revenues and increased margins
Gross profit margin3 increased by 180 basis points due to a higher proportion of growth in Jamieson Brands sales
EBITDA1 increased by $0.4 million to $64.3 million, mainly driven by higher revenues and gross profit; Adjusted EBITDA1 increased by $8.1 million, reflecting the impact of higher sales volumes, partially offset by investments in SG&A
Net earnings was $37.6 million; Adjusted net earnings1 was $38.5 million, or $3.9 million higher, reflecting higher normalized earnings from operations
Diluted earnings per share was $0.86; Adjusted diluted earnings per share2 was $0.90
Summary of Fourth Quarter Segment Results
All comparisons are with the fourth quarter of 2024
Jamieson Brands
Gross profit increased $18.6 million to $113.0 million; normalized gross profit increased by $18.3 million
Gross profit margin3 increased by 100 bps; normalized gross profit margin increased by 90 bps to 47.6% mainly driven by higher volumes in China, the Company’s highest gross margin business
Adjusted EBITDA1 increased $8.6 million to $62.9 million driven by higher gross profit and partially offset by SG&A due to performance marketing campaigns in China; Adjusted EBITDA margin2 decreased by 30 bps to 26.5%, consistent with prior year while slightly impacted by timing of variable compensation in SG&A in the prior year
Strategic Partners
All comparisons are with the fourth quarter of 2024
Revenue decreased by an expected 4.4% to $40.3 million, impacted by a reduction in business and the timing of onboarding new customer contracts amidst trade and tariff uncertainties
Gross profit was $5.7 million, a decrease of $0.1 million; gross profit margin3 was 14.1%, an increase of 30 bps, impacted by customer and product mix
Adjusted EBITDA1 was $4.7 million representing an Adjusted EBITDA margin2 of 11.6%, lower by 50 bps
Summary of Fourth Quarter Balance Sheet and Cash Flow from Operations
All comparisons are with the fourth quarter of 2024
As at December 31, 2025, the Company had approximately $126.6 million in cash and available revolving and swingline facilities and net debt1 of $373.4 million
The Company generated $31.9 million in cash from operations compared to $37.8 million generated in Q4 2024
Cash from operating activities before working capital considerations was $12.9 million higher than Q4 2024
Cash invested in working capital increased by $18.8 million mainly due to increased inventories to support the growth of the business and securing supply amidst tariff uncertainties and port congestion
During the three-month period ended December 31, 2025, the Company purchased 532,780 common shares for cancellation under its NCIB program for an aggregate consideration of $18.1 million
Summary of Fiscal 2025 Consolidated Results
All comparisons are with the fiscal year ended December 31, 2024
Consolidated revenue increased 12.0% to $822.1 million driven by 15.6% growth in Jamieson Brands revenue, partially offset by a 9.1% decline in Strategic Partners revenue, which was impacted by reductions in customer specific programs and timing of onboarding new customer contracts amidst trade and tariff uncertainties
Adjusted EBITDA1 increased by $18.7 million or 13.3% to $159.7 million
Net earnings were $64.5 million; Adjusted net earnings increased 15.0% to $79.4 million
Diluted earnings per share was $1.46; Adjusted diluted earnings per share2 was $1.85
1 This is a non-IFRS financial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each non-IFRS financial measure.
2 This is a non-IFRS ratio. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each non-IFRS ratio.
3 This is a supplementary financial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each supplementary financial measure.
Fiscal 2026 Outlook
All comparisons are with the fiscal year ended December 31, 2025
In fiscal 2026 the Company expects:
Consolidated revenue of between $895.0 million and $935.0 million, representing growth of 9.0% to 13.7%
Jamieson Brands revenue of $790.0 million to $820.0 million, or growth of between 8.7% and 12.9%. Beginning Q1 2026, youtheory branded revenue is allocated to its respective geographic business unit, rather than consolidated under youtheory (U.S.) as previously disclosed.
China: building on strong 2025 momentum and a significantly scaled consumer base, revenue is expected to grow between 20.0% and 30.0%, driven by continued strong marketing programs, innovation, and distribution gains
U.S.: revenue is expected to grow between 14.0% and 19.0% in USD, reflecting continued digital marketing and sales expansion, innovation, and distribution gains
Canada: revenue growth between 4.0% and 6.0%, led by continued market leading quality marketing campaign, innovation, and digital growth
International: revenue growth between 10.0% and 15.0% in contracted base currency, primarily the US dollar, led by locally relevant innovation and distribution gains in key markets such as the Middle East and Eastern Europe
Strategic Partners revenue growth between 10.0% and 20.0%, driven by the full year impact of new programs and new customers
Consolidated Adjusted EBITDA between $174.0 and $181.0 million, or growth of 9.0% to 13.4%
Consolidated Adjusted EBITDA margins to be maintained at approximately 19.4%, reflecting ongoing margin expansion in each branded business segment offset by geographical mix
Adjusted diluted earnings per share of $2.08 to $2.21, or growth of 12.5% to 19.5%
The Company’s 2026 guidance reflects the current prevailing trade environment between the United States, Canada and other countries. To date, tariffs have not had a material impact on the Company’s overall financial performance, as most of these costs have been mitigated through flexible supply chain and operating efficiencies. The Company recognizes the trade environment is constantly changing, including upcoming USMCA negotiations which may introduce changes to cross-border trade requirements and associated costs. As a result, actual results may be impacted by future changes in global trade policies. For additional details on the Company’s fiscal 2026 outlook, including guidance for the first quarter of 2026, refer to the “Outlook” section in the management’s discussion and analysis of financial condition and results of operations (“MD&A”) for the three and twelve months ended December 31, 2025. The Company’s 2026 guidance is based on a number of key assumptions set forth in the section titled “Outlook – Key Assumptions” in the MD&A, which section is incorporated by reference into this press release.
Fourth Quarter Dividend
On February 26, 2026, the Company announced that the board of directors declared a cash dividend for the fourth quarter of 2025:
$0.23 per common share or approximately $9.5 million in total
Paid on March 16, 2026 to all common shareholders of record at the close of business on March 6, 2026
The Company has designated this dividend as an “eligible dividend” for the purposes of the Income Tax Act (Canada)
Consolidated Financial Statements and Management’s Discussion and Analysis
The Company’s audited consolidated annual financial statements and accompanying notes as at and for the three and twelve months ended December 31, 2025 and related 2025 MD&A are available under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the Investor Relations section of the Company’s website at https://investors.jamiesonwellness.com.
Conference Call
Management will host a conference call to discuss the Company’s fourth quarter and full year 2025 results at 5:00 p.m. ET today, February 26, 2026. To access:
About Jamieson Wellness
Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada’s #1 vitamins, minerals and supplements (“VMS”) brand. The Company’s youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information please visit www.jamiesonwellness.com.
Jamieson Wellness’ head office is located at 1 Adelaide Street East Suite 2200, Toronto, Ontario, Canada.
Forward-Looking Information
This press release may contain forward-looking information within the meaning of applicable securities legislation. Such information includes, but is not limited to, statements related to the Company’s anticipated results and its outlook for its 2026 revenue, Adjusted EBITDA, Adjusted EBITDA margins and Adjusted diluted earnings per share. Words such as “expect”, “anticipate”, “intend”, “may”, “will”, “estimate” and variations of such words and similar expressions are intended to identify such forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances, which could prove to be incorrect.
The forward-looking information in this press release is based on a number of assumptions, including our ability to pursue further strategic acquisitions; our ability to source raw materials and other inputs from our suppliers; our ability to continue to innovate product offerings that resonate with our target customer base; our ability to retain key management and personnel; our ability to continue to expand our international presence and grow our brand internationally; our ability to obtain and maintain existing financing on acceptable terms; currency exchange and interest rates; the impact of competition; changes to trends in our industry or global economic factors; and changes to laws, rules, regulations and global standards . The forward-looking information in this press release is also subject to a number of risks and uncertainties, many of which are beyond the Company’s control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include the factors discussed under “Risk Factors” in the Company’s Annual Information Form dated March 31, 2025 and under the “Risk Factors” section in the 2025 MD&A filed today, February 26, 2026. The Company cautions that the forgoing list of assumptions and risks is not exhaustive and other factors could also adversely affect the Company’s results.
The forward-looking information in this press release is given as of the date of this press release. The Company does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Jamieson Wellness Inc.
Selected Consolidated Financial Information
In thousands of Canadian dollars, except share and per share amounts
Three months ended
Twelve months ended
December 31
December 31
2025
2024
2025
2024
Revenue
277,659
244,781
822,056
733,780
Cost of sales
158,976
144,555
483,724
458,170
Gross profit
118,683
100,226
338,332
275,610
Gross profit margin
42.7
%
40.9
%
41.2
%
37.6
%
Selling, general and administrative expenses
58,890
49,082
216,164
174,489
Acquisition related adjustments
(3,766
)
(12,425
)
(3,766
)
(12,425
)
Share-based compensation
2,125
1,987
8,408
7,268
Earnings from operations
61,434
61,582
117,526
106,278
Operating margin
22.1
%
25.2
%
14.3
%
14.5
%
Foreign exchange loss
2,163
1,852
1,853
1,479
Interest expense and other financing costs
6,401
5,684
22,409
20,272
Accretion on preferred shares
–
2,220
3,427
8,729
Earnings before income taxes
52,870
51,826
89,837
75,798
Provision for income taxes
15,233
15,705
25,373
24,665
Net earnings
37,637
36,121
64,464
51,133
Net earnings attributable to:
Shareholders
36,833
36,810
62,437
51,914
Non-controlling interests
804
(689
)
2,027
(781
)
37,637
36,121
64,464
51,133
Adjusted net earnings
38,500
34,641
79,394
69,044
EBITDA
64,320
63,890
135,330
123,331
Adjusted EBITDA
67,571
59,437
159,706
141,003
Adjusted EBITDA margin
24.3
%
24.3
%
19.4
%
19.2
%
Weighted average number of shares
Basic
41,825,723
41,818,220
41,833,795
41,580,983
Diluted
42,919,362
43,179,260
42,882,406
42,843,210
Earnings per share attributable to common shareholders:
Basic, earnings per share
0.88
0.86
1.49
1.23
Diluted, earnings per share
0.86
0.84
1.46
1.19
Adjusted diluted, earnings per share
0.90
0.80
1.85
1.61
Jamieson Wellness Inc.
Consolidated Statements of Financial Position
In thousands of Canadian dollars
December 31,
December 31,
2025
2024
Assets
Current assets
Cash
41,225
44,787
Accounts receivable
199,245
228,031
Inventories
203,083
154,658
Derivatives
486
2,661
Prepaid expenses and other current assets
7,303
6,803
451,342
436,940
Non-current assets
Property, plant and equipment
117,342
103,591
Goodwill
279,644
287,503
Intangible assets
362,753
377,214
Deferred income tax
3,951
3,545
Total assets
1,215,032
1,208,793
Liabilities
Current liabilities
Accounts payable and accrued liabilities
155,266
137,653
Income taxes payable
2,894
4,373
Derivatives
3,971
2,982
Current portion of other long-term liabilities
12,014
27,673
174,145
172,681
Long-term liabilities
Long-term debt
414,597
308,285
Post-retirement benefits
1,282
1,209
Deferred income tax
68,855
64,467
Redeemable preferred shares
–
98,138
Other long-term liabilities
26,642
15,633
Total liabilities
685,521
660,413
Equity
Share capital
333,347
326,219
Warrants
14,705
14,705
Contributed surplus
27,494
23,835
Retained earnings
90,374
99,109
Accumulated other comprehensive income
19,498
41,313
Total shareholders’ equity
485,418
505,181
Non-controlling interests
44,093
43,199
Total equity
529,511
548,380
Total liabilities and equity
1,215,032
1,208,793
Non-IFRS and Other Financial Measures
This press release makes reference to certain financial measures, including non-IFRS financial measures that are historical, non-IFRS measures that are forward-looking, non-GAAP ratios and supplementary financial measures. Management uses these financial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of ongoing operations and in analyzing the Company’s business performance and trends. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company’s results of operations from management’s perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the Company’s financial information reported under IFRS. The Company uses the following non-IFRS financial measures: “EBITDA”, “Adjusted EBITDA” and “Adjusted net earnings”, the most directly comparable financial measure for each that is disclosed in its financial statements being net earnings, “normalized gross profit”, “normalized SG&A”, “normalized earnings from operations”, “cash from operating activities before working capital considerations” and “net debt”, the most directly comparable financial measures for each that is disclosed in its financial statements being gross profit, SG&A, earnings from operations, cash flows from operating activities, and long-term debt, respectively, the following non-IFRS ratios: “Adjusted EBITDA margin”, “Adjusted diluted earnings per share”, “normalized gross profit margin”, “normalized operating margin”, and the following supplementary financial measures: “gross profit margin” and “operating margin” to provide supplemental measures of the Company’s operating performance and thus highlight trends in the Company’s core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also uses non-IFRS and supplementary financial measures in order to prepare annual operating budgets and to determine components of management compensation. For an explanation of the composition of each such measure and the usefulness and additional uses of each by management, see the “How we Assess the Performance of our Business” section of the MD&A, which is incorporated by reference. See below for a quantitative reconciliation of each non-IFRS financial measure to its most directly comparable financial measure disclosed in the Company’s financial statements to which the measure relates.
The following tables provide a quantitative reconciliation of net earnings to EBITDA, Adjusted EBITDA, and Adjusted net earnings, as well as gross profit to normalized gross profit, SG&A to normalized SG&A, earnings from operations to normalized earnings from operations and net debt, each of which are non-IFRS financial measures (see the “Non-IFRS and Other Financial Measures” of this press release for further information on each non-IFRS financial measure) for the three and twelve months ended December 31, 2025.
Jamieson Wellness Inc.
Segment Information
In thousands of Canadian dollars, except as otherwise noted
Jamieson Brands
Three months ended
December 31
2025
2024
$ Change
% Change
Revenue
237,361
202,621
34,740
17.1
%
Gross profit
112,992
94,395
18,597
19.7
%
Labour relations costs (1)
–
315
(315
)
(100.0
%)
Normalized gross profit
112,992
94,710
18,282
19.3
%
Gross profit margin
47.6
%
46.6
%
–
1.0
%
Normalized gross profit margin
47.6
%
46.7
%
–
0.9
%
Share-based compensation (2)
2,125
1,987
138
6.9
%
Selling, general and administrative expenses
57,187
47,621
9,566
20.1
%
Labour relations costs (1)
–
(462
)
462
100.0
%
IT system implementation (3)
(799
)
(2,141
)
1,342
62.7
%
Due diligence, legal, and other (4)
(1,930
)
(1,215
)
(715
)
(58.8
%)
Normalized selling, general and administrative expenses
54,458
43,803
10,655
24.3
%
Earnings from operations
57,446
57,212
234
0.4
%
Labour relations costs (1)
–
777
(777
)
(100.0
%)
IT system implementation (3)
799
2,141
(1,342
)
(62.7
%)
Acquisition related purchase consideration adjustments (5)
(3,766
)
(12,425
)
8,659
69.7
%
Due diligence, legal, and other (4)
1,930
1,215
715
58.8
%
Normalized earnings from operations
56,409
48,920
7,489
15.3
%
Operating margin
24.2
%
28.2
%
–
(4.0
%)
Normalized operating margin
23.8
%
24.1
%
–
(0.3
%)
Adjusted EBITDA
62,908
54,341
8,567
15.8
%
Adjusted EBITDA margin
26.5
%
26.8
%
–
(0.3
%)
Strategic Partners
Three months ended
December 31
2025
2024
$ Change
% Change
Revenue
40,298
42,160
(1,862
)
(4.4
%)
Gross profit
5,691
5,831
(140
)
(2.4
%)
Gross profit margin
14.1
%
13.8
%
–
0.3
%
Selling, general and administrative expenses
1,703
1,461
242
16.6
%
Earnings from operations
3,988
4,370
(382
)
(8.7
%)
Operating margin
9.9
%
10.4
%
–
(0.5
%)
Adjusted EBITDA
4,663
5,096
(433
)
(8.5
%)
Adjusted EBITDA margin
11.6
%
12.1
%
–
(0.5
%)
Jamieson Wellness Inc.
Segment Information (continued)
In thousands of Canadian dollars, except as otherwise noted
Jamieson Brands
Twelve months ended
December 31
2025
2024
$ Change
% Change
Revenue
726,582
628,744
97,838
15.6
%
Gross profit
326,286
262,065
64,221
24.5
%
Labour relations costs (1)
–
5,028
(5,028
)
(100.0
%)
IT system implementation (3)
1,023
–
1,023
100.0
%
Due diligence, legal, and other (4)
–
165
(165
)
(100.0
%)
Normalized gross profit
327,309
267,258
60,051
22.5
%
Gross profit margin
44.9
%
41.7
%
–
3.2
%
Normalized gross profit margin
45.0
%
42.5
%
–
2.5
%
Share-based compensation (2)
8,408
7,268
1,140
15.7
%
Selling, general and administrative expenses
209,809
168,459
41,350
24.5
%
IT system implementation (3)
(10,244
)
(11,562
)
1,318
11.4
%
Labour relations costs (1)
–
(2,137
)
2,137
100.0
%
Donations (6)
(3,118
)
–
(3,118
)
(100.0
%)
Due diligence, legal, and other (4)
(3,270
)
(2,458
)
(812
)
(33.0
%)
Normalized selling, general and administrative expenses
193,177
152,302
40,875
26.8
%
Earnings from operations
111,835
98,763
13,072
13.2
%
IT system implementation (3)
11,267
11,562
(295
)
(2.6
%)
Labour relations costs (1)
–
7,165
(7,165
)
(100.0
%)
Donations (6)
3,118
–
3,118
100.0
%
Acquisition related purchase consideration and post-closing adjustments (5)
(3,766
)
(12,425
)
8,659
69.7
%
Due diligence, legal, and other (4)
3,270
2,623
647
24.7
%
Normalized earnings from operations
125,724
107,688
18,036
16.7
%
Operating margin
15.4
%
15.7
%
–
(0.3
%)
Normalized operating margin
17.3
%
17.1
%
–
0.2
%
Adjusted EBITDA
151,105
130,496
20,609
15.8
%
Adjusted EBITDA margin
20.8
%
20.8
%
–
–
Strategic Partners
Twelve months ended
December 31
2025
2024
$ Change
% Change
Revenue
95,474
105,036
(9,562
)
(9.1
%)
Gross profit
12,046
13,545
(1,499
)
(11.1
%)
IT system implementation (3)
226
–
226
100.0
%
Normalized gross profit
12,272
13,545
(1,273
)
(9.4
%)
Gross profit margin
12.6
%
12.9
%
–
(0.3
%)
Normalized gross profit margin
12.9
%
12.9
%
–
–
Selling, general and administrative expenses
6,355
6,030
325
5.4
%
Earnings from operations
5,691
7,515
(1,824
)
(24.3
%)
IT system implementation (3)
226
–
226
100.0
%
Normalized earnings from operations
5,917
7,515
(1,598
)
(21.3
%)
Operating margin
6.0
%
7.2
%
–
(1.2
%)
Normalized operating margin
6.2
%
7.2
%
–
(1.0
%)
Adjusted EBITDA
8,601
10,507
(1,906
)
(18.1
%)
Adjusted EBITDA margin
9.0
%
10.0
%
–
(1.0
%)
Reconciliation of Non-IFRS Financial Measures
In thousands of Canadian dollars
Three months ended
Twelve months ended
December 31
December 31
2025
2024
2025
2024
Net earnings:
37,637
36,121
64,464
51,133
Add:
Recovery of income taxes
15,233
15,705
25,373
24,665
Interest expense and other financing costs
6,401
5,684
22,409
20,272
Accretion on preferred shares
–
2,220
3,427
8,729
Depreciation of property, plant, and equipment
3,431
2,635
13,579
12,588
Amortization of intangible assets
1,618
1,525
6,078
5,944
Earnings before interest, taxes, depreciation, and amortization (EBITDA)
64,320
63,890
135,330
123,331
Share-based compensation (2)
2,125
1,987
8,408
7,268
Foreign exchange loss
2,163
1,852
1,853
1,479
Labour relations costs (1)
–
777
–
7,165
IT system implementation (3)
799
2,141
11,493
11,562
Acquisition related purchase consideration and post-closing adjustments (5)
(3,766
)
(12,425
)
(3,766
)
(12,425
)
Donations (6)
–
–
3,118
–
Due diligence, legal, and other (4)
1,930
1,215
3,270
2,623
Adjusted EBITDA
67,571
59,437
159,706
141,003
Recovery of income taxes
(15,233
)
(15,705
)
(25,373
)
(24,665
)
Interest expense and other financing costs
(6,401
)
(5,684
)
(22,409
)
(20,272
)
Depreciation of property, plant, and equipment
(3,431
)
(2,635
)
(13,579
)
(12,588
)
Amortization of intangible assets
(1,618
)
(1,525
)
(6,078
)
(5,944
)
Share-based compensation (2)
(2,003
)
(1,865
)
(7,920
)
(6,780
)
Tax deduction from vesting of certain share-based awards
–
–
(708
)
–
Tax effect of normalization adjustments
(385
)
2,618
(4,245
)
(1,710
)
Adjusted net earnings
38,500
34,641
79,394
69,044
Three months ended
Twelve months ended
December 31
December 31
2025
2024
2025
2024
Gross profit
118,683
100,226
338,332
275,610
Labour relations costs (1)
–
315
–
5,028
Due diligence, legal, and other (4)
–
–
–
165
IT system implementation (3)
–
–
1,249
–
Normalized gross profit
118,683
100,541
339,581
280,803
Normalized gross profit margin
42.7
%
41.1
%
41.3
%
38.3
%
Selling, general and administrative expenses
58,890
49,082
216,164
174,489
IT system implementation (3)
(799
)
(2,141
)
(10,244
)
(11,562
)
Labour relations costs (1)
–
(462
)
–
(2,137
)
Donations (6)
–
–
(3,118
)
–
Due diligence, legal, and other (4)
(1,930
)
(1,215
)
(3,270
)
(2,458
)
Normalized selling, general and administrative expenses
56,161
45,264
199,532
158,332
Earnings from operations
61,434
61,582
117,526
106,278
Acquisition related purchase consideration and post-closing adjustments (5)
(3,766
)
(12,425
)
(3,766
)
(12,425
)
IT system implementation (3)
799
2,141
11,493
11,562
Donations (6)
–
–
3,118
–
Labour relations costs (1)
–
777
–
7,165
Due diligence, legal, and other (4)
1,930
1,215
3,270
2,623
Normalized earnings from operations
60,397
53,290
131,641
115,203
Normalized operating margin
21.8
%
21.8
%
16.0
%
15.7
%
(1)
These expenses are mainly comprised of third-party legal, security fees, unavoidable facility expenditures, customer fines and penalties, along with freight charges to expedite shipments to customers as it relates to a labour disruption in Q1 2024.
(2)
Our share-based compensation expense pertains to our long-term incentive plan (the “LTIP”), with stock options, performance-based share units (“PSUs”), time-based restricted share units (“RSUs”), and deferred share units (“DSUs”) expenses, along with associated payroll taxes.
(3)
Mainly pertains to development and post implementation start-up costs associated with our IT system implementation to augment our system infrastructure. Unlike other system improvement projects with costs capitalized, due to its cloud-based nature, these system implementation costs are expensed accordingly.
(4)
Includes professional service fees relating to completed due diligence costs for an unsuccessful acquisition and other non-recurring expenses primarily relating to non-operational legal costs.
(5)
To adjust for the fair value of purchase consideration accounted for as compensation in the 2022 youtheory acquisition, net of post-acquisition working capital adjustments to reflect acquired liabilities.
(6)
Include cash and in-kind donations to support communities adjacent to our Irvine, California facility impacted by the wildfires.
Reconciliation of Net Debt
In thousands of Canadian dollars
($ in 000’s)
As at December 31,
As at December 31,
2025
2024
Long-term debt
414,597
308,285
Cash
(41,225
)
(44,787
)
Net debt
373,372
263,498
View source version on businesswire.com: https://www.businesswire.com/news/home/20260226619502/en/
Contacts
Investor Relations and Media Contact Information:
Jamieson Wellness
Ruth Winker
416-960-0052
rwinker@jamiesonlabs.com
